About
United Immunity develops innovative immune-targeted drug delivery systems using pluronic-based nanoparticles to selectively deliver therapeutic agents to myeloid cells such as macrophages and dendritic cells for treatment of cancer, infectious diseases, autoimmune disorders, fibrosis, and metabolic diseases.
Explore United Immunity Co., Ltd's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.